“…For instance, the levels of calcium activity are increased in AD patients (Johnson et al, ) and elevated Ca 2+ induce BACE1 expression and consequently result in an increase in Aβ production (Cho, Jin, Youn, Huh, & Mook‐Jung, ; Mata, ) and cell death (Pierrot, Ghisdal, Caumont, & Octave, ). However, contradictory results have shown that familial AD‐linked PS1 or PS2 mutation attenuates calcium entry and thus increasing Aβ production (Fedeli, Filadi, Rossi, Mammucari, & Pizzo, ; Yoo et al, ), whereas constitutive activation of Ca 2+ entry reduces Aβ secretion (Zeiger et al, ). Thus, genetic or pharmacological activation of TRPV1 may increase Ca 2+ influx, reduce APP processing, and consequently improve synaptic plasticity and memory in APP23/PS45 model mice of AD.…”